This talk was presented at the 2018 SAGES Meeting/16th World Congress of Endoscopic Surgery by Vedra Abdomerovic Augenstein during the Devil’s in the Details: MIS Retrorectus Approaches on April 13 2018
Keyword(s): abdominal wall defect, absorbable synthetic mesh, adjuvant chemotherapy, AHS, American Hernia Society, biologic mesh, biosynthetic mesh, clean contaminated, COBRA study, comorbidities, component separation, Denmark, Devils in the details, diabetics, external oblique release, fellows, guideline, hernia recurrence, hernia repair, high risk patients, implant, inguinal hernia, innovation, laparoscopic ventral hernia, lightweight mesh, long-term, mesh, mesh infection, mesh placement, mesh reinforcement, midweight mesh, modifiable risk factors, National Institutes of Health, Netherlands, NIH database, obese, onlay, polypropylene mesh, posterior rectus sheath, preperitoneal space, primary repair, rectrorectus repair, recurrence rate, research fellow, resident, retromuscular space, retrorectus approaches, review, Rives Stoppa repair, robotic CS, semilunar line, smokers, SSI, sublay repair, surgical congress, surgical site infection, synthetic mesh, technique, trial, umbilical hernia defect, ventral hernia, wound complications
Hernia evolution–2:01 Hernia 2012
Rives-Stoppa method–2:07 JACS 2003
Options–5:08
Citation–5:36 World J Surg 2016
When should we use mesh?–6:01 NEJM 2000
Mesh options–7:43 JACS 2015
Advantages of absorbable synthetic mesh–9:07
Vicryl mesh–9:24 Ann Surg 2017
Biologic mesh–10:05 JACS 2017
Hernia grading–10:56
Conclusion–11:14